FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2922844093> ?p ?o ?g. }

• W2922844093 endingPage "980" @default.
• W2922844093 startingPage "971" @default.
• W2922844093 abstract "Abstract Geriatric characteristics such as high age, multi-morbidity, polypharmacy and frailty are common in patients with atrial fibrillation (AF). In a retrospective study using a German claims database, effectiveness (ischaemic stroke/systemic embolism) and safety (intracerebral, gastrointestinal and major extracranial bleeding) were compared in patients with non-valvular AF starting non-vitamin K oral antagonists (NOACs) (apixaban, dabigatran and rivaroxaban) and phenprocoumon. Cox proportional hazards models were used to calculate adjusted hazard ratios, and interaction terms of the treatment group and geriatric status (defined by age ≥75 years, frailty, ≥ 4 co-morbidities and polypharmacy) were entered into the model. A total of 42,562 and 27,939 patients initiated NOAC and phenprocoumon treatment (mean age 74 years ± 11, 51% male) with a follow-up time of 147,785 person-years. Note that 52.9% of patients were elderly, 50.8% were frail, 37.0% were co-morbid and 46.5% had polypharmacy. NOAC use was not associated with effectiveness and gastrointestinal bleeding, neither in geriatric nor in non-geriatric patients. The hazard of major extracranial and intracranial bleeding was significantly decreased for NOAC use, with similar risk reduction in geriatric and non-geriatric patients: major extracranial bleeding 0.70 (95% confidence interval [CI], 0.56–0.87) to 0.73 (95% CI, 0.60–0.89) for the geriatric groups and 0.71 (95% CI, 0.56–0.93) to 0.76 (0.59–0.98) for the non-geriatric groups (p-values for interaction > 0.6); and intracranial bleeding 0.52 (95% CI, 0.39–0.69) to 0.59 (95% CI, 0.47–0.73) for the geriatric groups and 0.54 (95% CI, 0.37–0.79) to 0.65 (95% CI, 0.49–0.86) for the non-geriatric groups (p-values for interaction > 0.2). Hence, NOACs showed similar effectiveness and superior safety in geriatric and non-geriatric patients." @default.
• W2922844093 created "2019-04-01" @default.
• W2922844093 creator A5009430890 @default.
• W2922844093 creator A5025733765 @default.
• W2922844093 creator A5028085559 @default.
• W2922844093 creator A5039578358 @default.
• W2922844093 creator A5053048440 @default.
• W2922844093 creator A5053599713 @default.
• W2922844093 date "2019-03-21" @default.
• W2922844093 modified "2023-09-23" @default.
• W2922844093 title "Non-Vitamin K Oral Anticoagulants in Comparison to Phenprocoumon in Geriatric and Non-Geriatric Patients with Non-Valvular Atrial Fibrillation" @default.
• W2922844093 cites W1938064655 @default.
• W2922844093 cites W2010706445 @default.
• W2922844093 cites W2011923415 @default.
• W2922844093 cites W2031654814 @default.
• W2922844093 cites W2067443499 @default.
• W2922844093 cites W208576153 @default.
• W2922844093 cites W2089939521 @default.
• W2922844093 cites W2094946296 @default.
• W2922844093 cites W2096246254 @default.
• W2922844093 cites W2097854437 @default.
• W2922844093 cites W2136489990 @default.
• W2922844093 cites W2142514031 @default.
• W2922844093 cites W2154388729 @default.
• W2922844093 cites W2159975225 @default.
• W2922844093 cites W2160965212 @default.
• W2922844093 cites W2162508946 @default.
• W2922844093 cites W2166154381 @default.
• W2922844093 cites W2167698566 @default.
• W2922844093 cites W2219896033 @default.
• W2922844093 cites W2323641853 @default.
• W2922844093 cites W2442037294 @default.
• W2922844093 cites W2482618273 @default.
• W2922844093 cites W2507258517 @default.
• W2922844093 cites W2509795914 @default.
• W2922844093 cites W2606119962 @default.
• W2922844093 cites W2606922710 @default.
• W2922844093 cites W2609718610 @default.
• W2922844093 cites W2760963070 @default.
• W2922844093 cites W2767010212 @default.
• W2922844093 cites W2784740969 @default.
• W2922844093 cites W2805702003 @default.
• W2922844093 cites W2885400827 @default.
• W2922844093 cites W3004050106 @default.
• W2922844093 doi "https://doi.org/10.1055/s-0039-1683422" @default.
• W2922844093 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30900223" @default.
• W2922844093 hasPublicationYear "2019" @default.
• W2922844093 type Work @default.
• W2922844093 sameAs 2922844093 @default.
• W2922844093 citedByCount "44" @default.
• W2922844093 countsByYear W29228440932016 @default.
• W2922844093 countsByYear W29228440932019 @default.
• W2922844093 countsByYear W29228440932020 @default.
• W2922844093 countsByYear W29228440932021 @default.
• W2922844093 countsByYear W29228440932022 @default.
• W2922844093 countsByYear W29228440932023 @default.
• W2922844093 crossrefType "journal-article" @default.
• W2922844093 hasAuthorship W2922844093A5009430890 @default.
• W2922844093 hasAuthorship W2922844093A5025733765 @default.
• W2922844093 hasAuthorship W2922844093A5028085559 @default.
• W2922844093 hasAuthorship W2922844093A5039578358 @default.
• W2922844093 hasAuthorship W2922844093A5053048440 @default.
• W2922844093 hasAuthorship W2922844093A5053599713 @default.
• W2922844093 hasConcept C118552586 @default.
• W2922844093 hasConcept C126322002 @default.
• W2922844093 hasConcept C127413603 @default.
• W2922844093 hasConcept C141071460 @default.
• W2922844093 hasConcept C207103383 @default.
• W2922844093 hasConcept C2775876007 @default.
• W2922844093 hasConcept C2776301958 @default.
• W2922844093 hasConcept C2778661090 @default.
• W2922844093 hasConcept C2778810321 @default.
• W2922844093 hasConcept C2779161974 @default.
• W2922844093 hasConcept C2780638905 @default.
• W2922844093 hasConcept C2780645631 @default.
• W2922844093 hasConcept C36434225 @default.
• W2922844093 hasConcept C44249647 @default.
• W2922844093 hasConcept C54183767 @default.
• W2922844093 hasConcept C71924100 @default.
• W2922844093 hasConcept C78519656 @default.
• W2922844093 hasConceptScore W2922844093C118552586 @default.
• W2922844093 hasConceptScore W2922844093C126322002 @default.
• W2922844093 hasConceptScore W2922844093C127413603 @default.
• W2922844093 hasConceptScore W2922844093C141071460 @default.
• W2922844093 hasConceptScore W2922844093C207103383 @default.
• W2922844093 hasConceptScore W2922844093C2775876007 @default.
• W2922844093 hasConceptScore W2922844093C2776301958 @default.
• W2922844093 hasConceptScore W2922844093C2778661090 @default.
• W2922844093 hasConceptScore W2922844093C2778810321 @default.
• W2922844093 hasConceptScore W2922844093C2779161974 @default.
• W2922844093 hasConceptScore W2922844093C2780638905 @default.
• W2922844093 hasConceptScore W2922844093C2780645631 @default.
• W2922844093 hasConceptScore W2922844093C36434225 @default.
• W2922844093 hasConceptScore W2922844093C44249647 @default.
• W2922844093 hasConceptScore W2922844093C54183767 @default.
• W2922844093 hasConceptScore W2922844093C71924100 @default.
• W2922844093 hasConceptScore W2922844093C78519656 @default.
• W2922844093 hasIssue "06" @default.

• next